Fig. 6From: Polymeric nanomedicines for the treatment of hepatic diseases(Reprinted with permission from Ref. [105], Copyright 2019, Elsevier Ltd)A Schematic illustration of Nifedipine nanoparticles (NFD-NPs) for preventing NAFLD. B NFD-NPs alleviate high-fat diet (HFD)-induced obesity and hepatic steatosis. C and D NFD-NPs improve insulin sensitivity and glucose tolerance.Back to article page